The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Professor Freddie Hamdy - who advised the Government not to offer more men the PSA blood test - explains why very slow growing tumours should be left well alone ...

Routine health check-ups are strangely not as common as they should in India. Doctors often advise getting annual check-ups to test for risk of various non-communicable diseases, the burden of which ...

Prostate health remains a crucial topic that many men avoid discussing, even with close family members. Early screenings can make a significant difference in detecting issues before they become severe ...

When it comes to prostate cancer, there’s a lot of confusion and guesswork floating around—especially among men who don’t ...

McGill University scientists have uncovered how loss of the protein ERRγ drives lethal neuroendocrine prostate cancer and identified a two-drug combination that significantly slows tumour growth in ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...